{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T19:34:18Z","timestamp":1786649658308,"version":"build-2736575974"},"reference-count":34,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Many studies have assessed the possible inhibitors for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). However, experiences like that from human immunodeficiency virus have taught us that a multidrug approach will reduce the chance of viral resistance.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and Methods:<\/jats:title>\n                    <jats:p>Here, we screened 2371 Food and Drug Administration-approved drugs for possible inhibition of nonstructural proteins of SARS-CoV-2 and expanded the work to include ligands that might interfere with the roles of structural proteins. Three different algorithms were used and suggested hits obtained using qVina were verified using Autodock Vina and leDock software.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Our results suggest direct-acting antivirals against hepatitis C might be efficient against SARS-CoV-2.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>Drug repurposing is a promising approach for the rapid identification of potential treatments for emerging diseases such as coronavirus disease.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/abr.abr_138_23","type":"journal-article","created":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T14:01:59Z","timestamp":1767103319000},"update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Identification of Candidate Inhibitors to SARS-CoV-2\u2019s Enzymes and Potential Disruptors of Its Structural Proteins\u2019 Interactions"],"prefix":"10.4103","volume":"14","author":[{"given":"Ali","family":"Mohammadian","sequence":"first","affiliation":[{"name":"Faculty of Biotechnology, Amol University of Special Modern Technologies, Amol, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahdieh","family":"Jadaliha","sequence":"additional","affiliation":[{"name":"Department of Biotechnology, Faculty of Sciences, University of Tehran, Tehran, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aylar","family":"Imanpour","sequence":"additional","affiliation":[{"name":"Regenerative Medicine Group (REMED), Universal Scientific Education and Research Network (USERN), Tehran, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamed","family":"Pourvali Moghadam","sequence":"additional","affiliation":[{"name":"Deptartment of Computer Engineering, Sharif University of Technology, Tehran, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"AmirHossein","family":"Jahangir","sequence":"additional","affiliation":[{"name":"Deptartment of Computer Engineering, Sharif University of Technology, Tehran, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,12]]},"reference":[{"key":"R1-20251230","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/S0140-6736(23)00115-0","article-title":"Conflicting COVID-19 excess mortality estimates","volume":"401","author":"Bager","year":"2023","journal-title":"Lancet"},{"key":"R2-20251230","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1038\/s41591-022-02185-4","article-title":"A survey of COVID-19 vaccine acceptance across 23 countries in 2022","volume":"29","author":"Lazarus","year":"2023","journal-title":"Nat Med"},{"key":"R4-20251230","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/j.apsb.2020.02.008","article-title":"Analysis of therapeutic targets for SARS-CoV-2 and discovery of potential drugs by computational methods","volume":"10","author":"Wu","year":"2020","journal-title":"Acta Pharm Sin B"},{"key":"R5-20251230","doi-asserted-by":"crossref","first-page":"e09910","DOI":"10.1016\/j.heliyon.2022.e09910","article-title":"Variations of SARS-CoV-2 in the Iranian population and candidate putative drug-like compounds to inhibit the mutated proteins","volume":"8","author":"Mortezaei","year":"2022","journal-title":"Heliyon"},{"key":"R6-20251230","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1007\/s10989-019-09891-7","article-title":"Structure based screening for inhibitory therapeutics of CTLA-4 unveiled new insights about biology of ACTH","volume":"26","author":"Ramezani","year":"2020","journal-title":"Int J Pept Res Ther"},{"key":"R7-20251230","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.dsx.2020.04.020","article-title":"Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): An overview of viral structure and host response","volume":"14","author":"Astuti","year":"2020","journal-title":"Diabetes Metab Syndr"},{"key":"R9-20251230","doi-asserted-by":"crossref","first-page":"D1074","DOI":"10.1093\/nar\/gkx1037","article-title":"DrugBank 5.0: A major update to the DrugBank database for 2018","volume":"46","author":"Wishart","year":"2018","journal-title":"Nucleic Acids Res"},{"key":"R11-20251230","first-page":"20786","article-title":"In-silico analysis of inhibitory action of garlic against hyperlipidemia by FAS enzyme","volume":"10","author":"Bhadra","year":"2020","journal-title":"Indian J Nat Sci"},{"key":"R12-20251230","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/1758-2946-3-33","article-title":"Open Babel: An open chemical toolbox","volume":"3","author":"O\u2019Boyle","year":"2011","journal-title":"J Cheminform"},{"key":"R13-20251230","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1038\/nprot.2016.051","article-title":"Computational protein\u2013ligand docking and virtual drug screening with the AutoDock suite","volume":"11","author":"Forli","year":"2016","journal-title":"Nat Protoc"},{"issue":"Suppl 1","key":"R14-20251230","doi-asserted-by":"crossref","first-page":"D302","DOI":"10.1093\/nar\/gkj120","article-title":"The RCSB PDB information portal for structural genomics","volume":"34","author":"Kouranov","year":"2006","journal-title":"Nucleic Acids Res"},{"key":"R15-20251230","article-title":"Protein Structure Modeling with MODELLER","author":"Webb","year":"2021","journal-title":"Springer"},{"key":"R16-20251230","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.3390\/molecules25112529","article-title":"In silico evaluation of the effectivity of approved protease inhibitors against the main protease of the novel SARS-CoV-2 virus","volume":"25","author":"Eleftheriou","year":"2020","journal-title":"Molecules"},{"key":"R17-20251230","article-title":"Effects of social Distancing and Isolation Modeled Via Dynamical Density Functional Theory","author":"Te","year":"2021","journal-title":"APS March Meeting Abstracts"},{"key":"R18-20251230","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1038\/s41579-020-00461-z","article-title":"Considerations for diagnostic COVID-19 tests","volume":"19","author":"Vandenberg","year":"2021","journal-title":"Nat Rev Microbiol"},{"key":"R19-20251230","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.cmi.2020.11.028","article-title":"Definitions for coronavirus disease 2019 reinfection, relapse and PCR re-positivity","volume":"27","author":"Yahav","year":"2021","journal-title":"Clin Microbiol Infect"},{"key":"R20-20251230","first-page":"10","article-title":"Investigational treatments for COVID-19","volume":"304","author":"Trivedi","year":"2020","journal-title":"Pharma J"},{"key":"R21-20251230","article-title":"Drug repurposing of approved drugs elbasvir, ledipasvir, paritaprevir, velpatasvir, antrafenine and ergotamine for combating COVID19","author":"Mevada","year":"2020","journal-title":"Biol Med Chem"},{"key":"R22-20251230","article-title":"Computational target-based drug repurposing of elbasvir, an antiviral drug predicted to bind multiple SARS-CoV-2 proteins","author":"Balasubramaniam","year":"2020","journal-title":"ChemRxiv"},{"key":"R23-20251230","doi-asserted-by":"crossref","first-page":"129","DOI":"10.12688\/f1000research.22457.2","article-title":"Prediction of the SARS-CoV-2 (2019-nCoV) 3C-like protease (3CL pro) structure: Virtual screening reveals velpatasvir, ledipasvir, and other drug repurposing candidates","volume":"9","author":"Chen","year":"2020","journal-title":"F1000Research"},{"key":"R24-20251230","doi-asserted-by":"crossref","first-page":"2679","DOI":"10.1080\/07391102.2020.1753577","article-title":"Targeting SARS-CoV-2: A systematic drug repurposing approach to identify promising inhibitors against 3C-like proteinase and 2\u2032-O-ribose methyltransferase","volume":"39","author":"Khan","year":"2021","journal-title":"J Biomol Struct Dyn"},{"key":"R25-20251230","doi-asserted-by":"crossref","first-page":"BSR20201256","DOI":"10.1042\/BSR20201256","article-title":"Glecaprevir and Maraviroc are high-affinity inhibitors of SARS-CoV-2 main protease: Possible implication in COVID-19 therapy","volume":"40","author":"Shamsi","year":"2020","journal-title":"Biosci Rep"},{"key":"R26-20251230","doi-asserted-by":"crossref","first-page":"118205","DOI":"10.1016\/j.lfs.2020.118205","article-title":"Anti-HCV and anti-malaria agent, potential candidates to repurpose for coronavirus infection: Virtual screening, molecular docking, and molecular dynamics simulation study","volume":"258","author":"Hosseini","year":"2020","journal-title":"Life Sci"},{"key":"R27-20251230","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1093\/jac\/dkaa501","article-title":"Sofosbuvir and daclatasvir for the treatment of COVID-19 outpatients: A double-blind, randomized controlled trial","volume":"76","author":"Roozbeh","year":"2021","journal-title":"J Antimicrob Chemother"},{"key":"R28-20251230","doi-asserted-by":"crossref","first-page":"55","DOI":"10.3201\/eid1201.051068","article-title":"Vaccines and antiviral drugs in pandemic preparedness","volume":"12","author":"Monto","year":"2006","journal-title":"Emerg Infect Dis"},{"key":"R29-20251230","doi-asserted-by":"crossref","first-page":"704205","DOI":"10.3389\/fphar.2021.704205","article-title":"The drug repurposing for COVID-19 clinical trials provide very effective therapeutic combinations: Lessons learned from major clinical studies","volume":"12","author":"Chakraborty","year":"2021","journal-title":"Front Pharmacol"},{"key":"R30-20251230","doi-asserted-by":"crossref","first-page":"174454","DOI":"10.1016\/j.ejphar.2021.174454","article-title":"Anti-cancer impact of Hypericin in B-CPAP cells: Extrinsic caspase dependent apoptosis induction and metastasis obstruction","volume":"910","author":"Piryaei","year":"2021","journal-title":"Eur J Pharmacol"},{"key":"R31-20251230","first-page":"349","article-title":"Hypericin induces apoptosis in AGS cell line with no significant effect on normal cells","volume":"19","author":"Naderi","year":"2020","journal-title":"Iran J Pharm Res"},{"key":"R32-20251230","doi-asserted-by":"crossref","first-page":"118874","DOI":"10.1016\/j.lfs.2020.118874","article-title":"Transcriptome analysis evinces anti-neoplastic mechanisms of hypericin: A study on U87 glioblastoma cell line","volume":"266","author":"Ghiasvand","year":"2021","journal-title":"Life Sci"},{"key":"R33-20251230","doi-asserted-by":"crossref","first-page":"e13154","DOI":"10.1111\/cpr.13154","article-title":"Cellular stress response to extremely low\u2010frequency electromagnetic fields (ELF\u2010EMF): An explanation for controversial effects of ELF\u2010EMF on apoptosis","volume":"54","author":"Barati","year":"2021","journal-title":"Cell Prolif"},{"key":"R34-20251230","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s12032-020-01448-9","article-title":"Integration of gene expression data identifies key genes and pathways in colorectal cancer","volume":"38","author":"Hozhabri","year":"2021","journal-title":"Med Oncol"},{"key":"R35-20251230","doi-asserted-by":"crossref","first-page":"10374","DOI":"10.1038\/s41598-022-14610-2","article-title":"A comprehensive bioinformatics analysis to identify potential prognostic biomarkers among CC and CXC chemokines in breast cancer","volume":"12","author":"Hozhabri","year":"2022","journal-title":"Sci Rep"},{"key":"R36-20251230","doi-asserted-by":"crossref","first-page":"e00515","DOI":"10.1002\/mgg3.515","article-title":"Gene coexpression network analysis identified potential biomarkers in gestational diabetes mellitus progression","volume":"7","author":"Zhao","year":"2019","journal-title":"Mol Genet Genomic Med"},{"key":"R37-20251230","doi-asserted-by":"crossref","first-page":"100975","DOI":"10.1016\/j.imu.2022.100975","article-title":"Network module analysis of bipolar disorder mechanism deciphers underlying pathways","volume":"31","author":"Rahnama","year":"2022","journal-title":"Inform Med Unlocked"}],"container-title":["Advanced Biomedical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/abr.abr_138_23","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T18:56:39Z","timestamp":1786647399000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/abr.abr_138_23"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.4103\/abr.abr_138_23","relation":{},"ISSN":["2277-9175"],"issn-type":[{"value":"2277-9175","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"2023-04-21","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-07-13","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}